Abeona Therapeutics Inc (NASDAQ: ABEO) stock enjoyed a major increase of 10.0% on 11/13/23. The shares closed at $4.50. The stock has been exceptionally strong relative to the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
ABEO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Abeona Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 95, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment